![Micki Klearman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Micki Klearman
Keine laufenden Positionen mehr
Profil
Micki Klearman worked as Associate Group Medical Director-Immunology at Genentech, Inc. from 2007 to 2018.
Dr. Klearman worked as Independent Director at Kezar Life Sciences, Inc. from 2021 to 2026.
Dr. Klearman completed undergraduate studies at Stanford University and earned a doctorate from Washington University School of Medicine.
Ehemalige bekannte Positionen von Micki Klearman
| Unternehmen | Position | Ende |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 11.05.2026 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Micki Klearman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
